ALSO NOTED: New warning added to Aptivus; Novartis increases NeuTec control; and much more...

> The warning on the AIDS drug Aptivus is being updated to include a warning that the drug has been linked to sometimes fatal cases of bleeding in the brain. Report

> Novartis has acquired 8.3 percent of NeuTec, bringing its total to 52 percent as it pursues plans to buy the British biotech. Report

> Japan's Astellas Pharma has picked three drugs in its pipeline for rapid development. Report

> Quantum Genomics of Jersey City, NJ has opened its European headquarters near Paris. Release

> Pfizer is cutting the price of some drugs that have lost patent protection in Switzerland. Report

> The board of Barr Pharmaceuticals says it can win the battle for control of Pliva. Report

And Finally... Scientists are discovering that cloned animals are often dramatically different from their originals. Article